Our in vitro biological model of drug resistance made use of the well characterized and widely utilized estrogen receptor positive (ERα+) MCF7 breast cancer cell line (parental), and its paired cell line selected for Doxorubicin resistance (DOXRes), using our previously published in vitro protocol [14, 15]. The gene discussed is ESR1; the disease is breast carcinoma.